Skip to main content
    P

    Protara Therapeutics Inc (TARA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $2.32
    -0.06 (-2.52%)

    Market Cap: $146.54M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Protara Therapeutics Inc (TARA) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Protara Therapeutics (TARA) has a latest price of $2.32 on Nov 17, 2026, 70.3% below its 52-week high of $7.82. Its price fell 57.9% over the past 12 months. The month-end price fell 99.4% over the 10 years through Oct 2026, a compound annual decline of 39.8%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $408.00 in Nov 2016 and its lowest $1.25 in Oct 2023, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart TARA with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for TARA.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 41.4%, and over 6 months it fell 46.5%. The month-end price rose 99.2% over the 3 years through Oct 2026, a compound annual rate of 25.8%.

    PeriodChange
    1 month-0.4%
    3 months-41.4%
    6 months-46.5%
    12 months-57.9%
    12 months, with dividends-57.9%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+99.2%+25.8%
    5 years-64.2%-18.6%
    10 years-99.4%-39.8%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2024, when the price rose 181.6%, and its weakest was 2019, when it fell 81.9%.

    YearCloseChange
    2026 through Oct 2026$2.48-53.5%
    2025$5.33+0.9%
    2024$5.28+181.6%
    2023$1.88-30.0%
    2022$2.68-60.3%
    2021$6.75-72.1%
    2020$24.21+47.6%
    2019$16.40-81.9%
    2018$90.80+19.5%
    2017$76.000.0%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 17.9% below its 50-day average of $2.83 and 46.4% below its 200-day average of $4.33.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$2.32
    52-week high$7.82-70.3%
    52-week low$2.09+11.0%
    50-day average$2.83-17.9%
    200-day average$4.33-46.4%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 71.8%.

    MeasureValue
    1-year beta1.32
    Largest fall, 1 year-71.8%
    Largest fall, 3 years-71.8%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About TARA

    What is TARA's 1-year price change?

    Protara Therapeutics's price fell 57.9% over the past 12 months. With dividends included, the 12-month total return was -57.9%.

    What is TARA's 5-year price change?

    Protara Therapeutics's month-end price fell 64.2% over the 5 years through Oct 2026, a compound annual decline of 18.6%. These figures leave out dividends.

    What is TARA's 52-week high and low?

    Protara Therapeutics's 52-week high is $7.82 and its 52-week low is $2.09. Its latest price of $2.32 on Nov 17, 2026 is 70.3% below the high.

    What is TARA's beta?

    Protara Therapeutics's 1-year beta against the S&P 500 is 1.32, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 71.8%.

    Is the TARA chart free?

    Yes. Advanced Charting for TARA is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.